Every SEC Form 3/4/5 on record for this filer (CIK 1364719) — 7 issuers, 163 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KYNB | KYNTRA BIO, INC. | Director | 2026-06-17 → 2026-06-17 | 1 | — |
| KZR | Kezar Life Sciences, Inc. | Director | 2018-06-20 → 2026-05-11 | 13 | −$82,250 |
| VSTM | Verastem, Inc. | President of Development · Director | 2016-02-17 → 2026-01-08 | 16 | −$79,105 |
| FGEN | FIBROGEN INC | Director | 2025-06-06 → 2025-06-06 | 2 | — |
| ACET | Adicet Bio, Inc. | Director | 2021-11-18 → 2024-08-23 | 7 | −$8,437 |
| KPTI | Karyopharm Therapeutics Inc. | Director · lapsed | 2016-01-20 → 2022-03-02 | 60 | −$10M |
| INFI | INFINITY PHARMACEUTICALS, INC. | Director · lapsed | 2017-04-06 → 2019-06-14 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| VSTM | 2025-11-21 | Sell | 8,550 | $10.00 | $85,500 | 8,666 |
| ACET | 2024-06-05 | Sell | 5,900 | $1.43 | $8,437 | 5,900 |
| KPTI | 2022-02-28 | Sell | 6,226 | $10.24 | $63,754 | 898,131 |
| KPTI | 2022-02-28 | Sell | 6,226 | $10.24 | $63,754 | 713,757 |
4 of 7 issuers are covered and open a security page; the rest are on file here only.
